CLAYTON, MO US

1. 20100305125 SALT OF ABT-263 AND SOLID-STATE FORMS THEREOF 12-02-2010
2. 20100297194 FORMULATION FOR ORAL ADMINISTRATION OF APOPTOSIS PROMOTER 11-25-2010
3. 20100280031 LIPID FORMULATION OF APOPTOSIS PROMOTER - orally deliverable pharmaceutical composition comprises a drug-carrier system having a Bcl-2 family protein 11-04-2010
4. 20100278921 SOLID ORAL FORMULATION OF ABT-263 - orally deliverable pharmaceutical composition comprises a pharmaceutically acceptable acid addition salt of ABT-263 11-04-2010
5. 20100278905 STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER 11-04-2010